Deal snapshot: SomaLogic Acquires DNA Nanotechnology Provider Palamedrix for USD 35m.

MANews-(C)2009-2022

Colorado, US-based SomaLogic (NASDAQ: SLGC), operating in AI data-driven proteomics technology has entered into an agreement to acquire California-based DNA nanotechnology provider Palamedrix, Inc. for USD 35m, the company said.

Under the terms of the merger agreement, SomaLogic...

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT